Geron
GERN
#6644
Rank
A$1.17 B
Marketcap
A$1.84
Share price
-3.73%
Change (1 day)
1.68%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -A$53.88 Million

According to Geron's latest financial reports the company's current earnings are A$0.19 Billion. In 2025 the company made an earning of -A$72.37 Million, an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$53.88 Million-25.55%
2025 -A$72.37 Million-67.42%
2024 -A$0.23 Billion-11.23%
2023 -A$0.26 Billion30.22%
2022 -A$0.2 Billion20.15%
2021 -A$0.16 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$44.23 Million8.84%
2017 -A$40.64 Million-3.08%
2016 -A$41.93 Million-22080.6%
2015 A$0.19 M-100.38%
2014 -A$50.66 Million-7.14%
2013 -A$54.55 Million
2011 -A$0.13 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$99.98 Million-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$89.45 Million32.68%
2006 -A$67.42 Million25.59%
2005 -A$53.68 Million4.36%
2004 -A$51.44 Million19.73%
2003 -A$42.96 Million-15.46%
2002 -A$50.82 Million1.94%
2001 -A$49.85 Million33.59%
2000 -A$37.32 Million27.53%
1999 -A$29.26 Million63.13%
1998 -A$17.94 Million15.6%
1997 -A$15.52 Million-10.66%
1996 -A$17.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$15.27 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.52 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$98.56 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.22 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$21.24 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA